Chronic wound state exacerbated by oxidative stress in Pax6+/-aniridia-related keratopathy

J. Ou, P. Walczysko, R. Kucerova, A. M. Rajnicek, C. D. McCaig, M. Zhao, J. M. Collinson

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Heterozygosity for the transcription factor PAX 6 causes eye disease in humans, characterized by, corneal opacity. The molecular aetiology of such disease was investigated using a Pax(+/-) mouse model. We found that the barrier function of uninjured Pax6(+/-) corneas was compromised and that Ca2+-PKC/PLC-ERK/p38 signalling pathways were abnormally activated, mimicking a 'wounded' epithelial state. Using proteomic analysis and direct assay for oxidized proteins, Pax6(+/-) corneas were found to be susceptible to oxidative stress and they exhibited a wound-healing delay which could be rescued by, providing reducing agents such as glutathione. Pax6 protein was oxidized and excluded from the nucleus of stressed corneal epithelial cells, with concomitant loss of corneal epithelial markers and expression of fibroblast/myolibroblast markers. We suggest a chronic wound model for Pax6-related corneal diseases, in which oxidative stress underlies a positive feedback mechanism by depleting nuclear Pax6, delaying wound healing, and activating cell signalling pathways that lead to metaplasia of the corneal epithelium. The study mechanistically links a relatively minor dosage deficiency of a transcription factor with potentially catastrophic degenerative corneal disease. Copyright (c) 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Original languageEnglish
Pages (from-to)421-430
Number of pages10
JournalThe Journal of pathology
Volume215
Issue number4
Early online date17 Apr 2008
DOIs
Publication statusPublished - Aug 2008

Keywords

  • aniridia
  • aniridic keratopathy
  • Pax6
  • cornea
  • oxidative stress
  • pharmacology
  • haploinsufficiency
  • metalloproteinase gelatinaseB
  • glutathione-S-transferase
  • activated protein-kinase
  • corneal epithelial-cells
  • aldehyde dehydrogenase
  • intracellular calcium
  • mouse model
  • map kinase
  • PAX6
  • expression

Cite this

Chronic wound state exacerbated by oxidative stress in Pax6+/-aniridia-related keratopathy. / Ou, J.; Walczysko, P.; Kucerova, R.; Rajnicek, A. M.; McCaig, C. D.; Zhao, M.; Collinson, J. M.

In: The Journal of pathology, Vol. 215, No. 4, 08.2008, p. 421-430.

Research output: Contribution to journalArticle

@article{1e90b0436a8f4f8f97faccfdcdb9a6fe,
title = "Chronic wound state exacerbated by oxidative stress in Pax6+/-aniridia-related keratopathy",
abstract = "Heterozygosity for the transcription factor PAX 6 causes eye disease in humans, characterized by, corneal opacity. The molecular aetiology of such disease was investigated using a Pax(+/-) mouse model. We found that the barrier function of uninjured Pax6(+/-) corneas was compromised and that Ca2+-PKC/PLC-ERK/p38 signalling pathways were abnormally activated, mimicking a 'wounded' epithelial state. Using proteomic analysis and direct assay for oxidized proteins, Pax6(+/-) corneas were found to be susceptible to oxidative stress and they exhibited a wound-healing delay which could be rescued by, providing reducing agents such as glutathione. Pax6 protein was oxidized and excluded from the nucleus of stressed corneal epithelial cells, with concomitant loss of corneal epithelial markers and expression of fibroblast/myolibroblast markers. We suggest a chronic wound model for Pax6-related corneal diseases, in which oxidative stress underlies a positive feedback mechanism by depleting nuclear Pax6, delaying wound healing, and activating cell signalling pathways that lead to metaplasia of the corneal epithelium. The study mechanistically links a relatively minor dosage deficiency of a transcription factor with potentially catastrophic degenerative corneal disease. Copyright (c) 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.",
keywords = "aniridia, aniridic keratopathy, Pax6, cornea, oxidative stress, pharmacology, haploinsufficiency, metalloproteinase gelatinaseB, glutathione-S-transferase, activated protein-kinase, corneal epithelial-cells, aldehyde dehydrogenase, intracellular calcium, mouse model, map kinase, PAX6, expression",
author = "J. Ou and P. Walczysko and R. Kucerova and Rajnicek, {A. M.} and McCaig, {C. D.} and M. Zhao and Collinson, {J. M.}",
year = "2008",
month = "8",
doi = "10.1002/path.2371",
language = "English",
volume = "215",
pages = "421--430",
journal = "The Journal of pathology",
issn = "0022-3417",
publisher = "Wiley",
number = "4",

}

TY - JOUR

T1 - Chronic wound state exacerbated by oxidative stress in Pax6+/-aniridia-related keratopathy

AU - Ou, J.

AU - Walczysko, P.

AU - Kucerova, R.

AU - Rajnicek, A. M.

AU - McCaig, C. D.

AU - Zhao, M.

AU - Collinson, J. M.

PY - 2008/8

Y1 - 2008/8

N2 - Heterozygosity for the transcription factor PAX 6 causes eye disease in humans, characterized by, corneal opacity. The molecular aetiology of such disease was investigated using a Pax(+/-) mouse model. We found that the barrier function of uninjured Pax6(+/-) corneas was compromised and that Ca2+-PKC/PLC-ERK/p38 signalling pathways were abnormally activated, mimicking a 'wounded' epithelial state. Using proteomic analysis and direct assay for oxidized proteins, Pax6(+/-) corneas were found to be susceptible to oxidative stress and they exhibited a wound-healing delay which could be rescued by, providing reducing agents such as glutathione. Pax6 protein was oxidized and excluded from the nucleus of stressed corneal epithelial cells, with concomitant loss of corneal epithelial markers and expression of fibroblast/myolibroblast markers. We suggest a chronic wound model for Pax6-related corneal diseases, in which oxidative stress underlies a positive feedback mechanism by depleting nuclear Pax6, delaying wound healing, and activating cell signalling pathways that lead to metaplasia of the corneal epithelium. The study mechanistically links a relatively minor dosage deficiency of a transcription factor with potentially catastrophic degenerative corneal disease. Copyright (c) 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

AB - Heterozygosity for the transcription factor PAX 6 causes eye disease in humans, characterized by, corneal opacity. The molecular aetiology of such disease was investigated using a Pax(+/-) mouse model. We found that the barrier function of uninjured Pax6(+/-) corneas was compromised and that Ca2+-PKC/PLC-ERK/p38 signalling pathways were abnormally activated, mimicking a 'wounded' epithelial state. Using proteomic analysis and direct assay for oxidized proteins, Pax6(+/-) corneas were found to be susceptible to oxidative stress and they exhibited a wound-healing delay which could be rescued by, providing reducing agents such as glutathione. Pax6 protein was oxidized and excluded from the nucleus of stressed corneal epithelial cells, with concomitant loss of corneal epithelial markers and expression of fibroblast/myolibroblast markers. We suggest a chronic wound model for Pax6-related corneal diseases, in which oxidative stress underlies a positive feedback mechanism by depleting nuclear Pax6, delaying wound healing, and activating cell signalling pathways that lead to metaplasia of the corneal epithelium. The study mechanistically links a relatively minor dosage deficiency of a transcription factor with potentially catastrophic degenerative corneal disease. Copyright (c) 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

KW - aniridia

KW - aniridic keratopathy

KW - Pax6

KW - cornea

KW - oxidative stress

KW - pharmacology

KW - haploinsufficiency

KW - metalloproteinase gelatinaseB

KW - glutathione-S-transferase

KW - activated protein-kinase

KW - corneal epithelial-cells

KW - aldehyde dehydrogenase

KW - intracellular calcium

KW - mouse model

KW - map kinase

KW - PAX6

KW - expression

U2 - 10.1002/path.2371

DO - 10.1002/path.2371

M3 - Article

VL - 215

SP - 421

EP - 430

JO - The Journal of pathology

JF - The Journal of pathology

SN - 0022-3417

IS - 4

ER -